Metabolic Profiling Associates with Disease Severity in Nonischemic Dilated Cardiomyopathy-Reference-Cited by-同舟云学术

Metabolic Profiling Associates with Disease Severity in Nonischemic Dilated Cardiomyopathy

Published:2020-03 Issue:3 Volume:26 Page:212-222
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Verdonschot Job A.J.,Wang Ping,Van Bilsen Marc,Hazebroek Mark R.,Merken Jort J.,Vanhoutte Els K.,Henkens Michiel T.H.M.,Van Den Wijngaard Arthur,Glatz Jan F.C.,Krapels Ingrid P.C.,Brunner Han G.,Heymans Stephane R.B.,Bierau Jörgen

Funder

Heart Foundation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. The diagnosis and evaluation of dilated cardiomyopathy;Japp;J Am Coll Cardiol,2016

2. The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease;Ussher;J Am Coll Cardiol,2016

3. Metabolic support for the heart: complementary therapy for heart failure?;Heggermont;Eur J Heart Fail,2016

4. Metabolomics: a wide-open door to personalized treatment in chronic heart failure?;Marcinkiewicz-Siemion;Int J Cardiol,2016

5. Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics;Cheng;J Am Coll Cardiol,2015

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3-Methylglutarylcarnitine: A biomarker of mitochondrial dysfunction;Clinica Chimica Acta;2023-11

2. Untargeted metabolomic profiling of dogs with myxomatous mitral valve disease and congestive heart failure shows metabolic differences associated with the presence of cardiac cachexia;American Journal of Veterinary Research;2023-10-11

3. Multi‐omic analyses and network biology in cardiovascular disease;PROTEOMICS;2023-09-10

4. Analysis of the role of glucose metabolism-related genes in dilated cardiomyopathy based on bioinformatics;Journal of Thoracic Disease;2023-07

5. Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers;Journal of Cardiovascular Translational Research;2023-06-06